|
humans |
47 |
|
female |
46 |
|
adult |
39 |
|
male |
34 |
|
middle aged |
33 |
|
osteoporosis |
30 |
|
aged |
22 |
|
chinese |
19 |
|
china |
18 |
|
bone density |
17 |
|
bone mineral density |
16 |
|
case-control studies |
14 |
|
aged, 80 and over |
13 |
|
animals |
13 |
|
cohort studies |
13 |
|
mice |
13 |
|
association |
12 |
|
bmd |
12 |
|
bone density - genetics |
12 |
|
hong kong |
12 |
|
prospective studies |
12 |
|
time factors |
12 |
|
polymorphism, single nucleotide |
11 |
|
pregnancy |
11 |
|
risk factors |
11 |
|
adolescent |
10 |
|
age factors |
10 |
|
follow-up studies |
10 |
|
haplotypes |
10 |
|
predictive value of tests |
10 |
|
cancer |
9 |
|
fracture |
9 |
|
incidence |
9 |
|
linkage |
9 |
|
risk |
9 |
|
treatment outcome |
9 |
|
absorptiometry, photon |
8 |
|
bone density - physiology |
8 |
|
calcium |
8 |
|
genetic predisposition to disease |
8 |
|
genotype |
8 |
|
hyperthyroidism |
8 |
|
low density lipoprotein receptor-related protein-5 |
8 |
|
pedigree |
8 |
|
asian continental ancestry group |
7 |
|
asian continental ancestry group - genetics |
7 |
|
cell line |
7 |
|
cer1 |
7 |
|
diabetes |
7 |
|
genetic linkage |
7 |
|
genetics |
7 |
|
genome-wide association study |
7 |
|
hong kong - epidemiology |
7 |
|
immunohistochemistry |
7 |
|
meta-analysis |
7 |
|
parathyroid hormone |
7 |
|
questionnaires |
7 |
|
southern chinese women |
7 |
|
thyrotropin - blood |
7 |
|
vitamin d |
7 |
|
absorptiometry, photon - methods |
6 |
|
alkaline phosphatase - blood |
6 |
|
allele |
6 |
|
animal cell |
6 |
|
antiresorptives |
6 |
|
area under curve |
6 |
|
atrial fibrillation |
6 |
|
atrial fibrillation - complications |
6 |
|
body mass index |
6 |
|
body weight |
6 |
|
bone density - drug effects |
6 |
|
bone metabolism |
6 |
|
brain ischemia - epidemiology - etiology |
6 |
|
cross-sectional studies |
6 |
|
cytokines - genetics |
6 |
|
disease and disorders of/related to bone |
6 |
|
dna-binding proteins - genetics - metabolism |
6 |
|
epidemiological studies |
6 |
|
epidemiology |
6 |
|
femur - metabolism |
6 |
|
follicle stimulating hormone - blood |
6 |
|
fractures, bone - genetics |
6 |
|
gene frequency |
6 |
|
general population studies |
6 |
|
genetic association |
6 |
|
genetic disease |
6 |
|
genome-wide haplotype association mapping (ham) |
6 |
|
hyperthyroidism - complications |
6 |
|
in situ hybridization |
6 |
|
ischemic stroke |
6 |
|
japan |
6 |
|
ldl-receptor related proteins - genetics |
6 |
|
lrp5 |
6 |
|
messenger rna |
6 |
|
mice, inbred strains |
6 |
|
mineral metabolism |
6 |
|
osteoblasts - metabolism |
6 |
|
osteoporosis - genetics - metabolism |
6 |
|
premenopause |
6 |
|
proportional hazards models |
6 |
|
proteins - genetics |
6 |
|
proto-oncogene proteins - genetics - metabolism |
6 |
|
quantitative trait loci |
6 |
|
reverse transcriptase polymerase chain reaction |
6 |
|
stroke |
6 |
|
therapeutics |
6 |
|
thyroiditis, autoimmune - immunology |
6 |
|
thyroxine - blood |
6 |
|
transcription factor gata 2 |
6 |
|
algorithms |
5 |
|
alleles |
5 |
|
association study |
5 |
|
base sequence |
5 |
|
bone density - genetics - physiology |
5 |
|
calcium, dietary - administration & dosage |
5 |
|
china - ethnology |
5 |
|
chromosomes, human, pair 1 |
5 |
|
chromosomes, human, pair 11 |
5 |
|
chromosomes, human, pair 14 |
5 |
|
complication |
5 |
|
diagnosis, differential |
5 |
|
fractures, bone - epidemiology - genetics |
5 |
|
hypophosphatemia - etiology |
5 |
|
latent tgf-beta binding proteins - genetics |
5 |
|
life style |
5 |
|
linkage disequilibrium |
5 |
|
lod score |
5 |
|
lumbosacral region - anatomy & histology |
5 |
|
pelvic bones - metabolism |
5 |
|
recurrence |
5 |
|
retrospective studies |
5 |
|
risk assessment |
5 |
|
sex factors |
5 |
|
spine - anatomy & histology - physiology |
5 |
|
testosterone - blood |
5 |
|
vertebral fracture |
5 |
|
25-hydroxyvitamin d |
4 |
|
abortion |
4 |
|
abortion, spontaneous - epidemiology - etiology |
4 |
|
acth syndrome, ectopic - complications - diagnosis |
4 |
|
adam questionnaire |
4 |
|
adrenocorticotropic hormone - analysis |
4 |
|
aging |
4 |
|
alkaline phosphatase - metabolism |
4 |
|
analysis of variance |
4 |
|
androgen deficiency |
4 |
|
androgens - blood - deficiency |
4 |
|
andropause |
4 |
|
antithyroid agents - therapeutic use |
4 |
|
asian continental ancestry group - statistics & numerical data |
4 |
|
atrial fibrillation - etiology - therapy |
4 |
|
autoantibodies - blood |
4 |
|
autoimmune thyroid disease |
4 |
|
autoimmune thyroiditis |
4 |
|
binding sites - genetics |
4 |
|
biomedicine |
4 |
|
blastocyst - immunology |
4 |
|
bone health |
4 |
|
bone metastases |
4 |
|
bone neoplasms - complications - diagnosis |
4 |
|
bone neoplasms - secondary |
4 |
|
caffeine |
4 |
|
calcitriol |
4 |
|
calcitriol - administration & dosage |
4 |
|
calcium - urine |
4 |
|
calcium-binding proteins - genetics |
4 |
|
candidate genes |
4 |
|
cdx1 |
4 |
|
cell adhesion molecules - genetics - metabolism |
4 |
|
child |
4 |
|
child development |
4 |
|
china - epidemiology |
4 |
|
chinese postmenopausal women |
4 |
|
chinese women |
4 |
|
cholesterol - blood |
4 |
|
coffee |
4 |
|
collagen type i - genetics |
4 |
|
cross-cultural comparison |
4 |
|
cushing syndrome - etiology |
4 |
|
cva |
4 |
|
diabetes mellitus |
4 |
|
diastole |
4 |
|
disease models, animal |
4 |
|
dual-energy x-ray absorptiometry |
4 |
|
ectopic acth syndrome |
4 |
|
electric countershock |
4 |
|
environment |
4 |
|
epstein- barr virus |
4 |
|
estradiol - blood |
4 |
|
estrogen receptor alpha - genetics |
4 |
|
estrogen receptor beta - genetics |
4 |
|
estrogen replacement therapy |
4 |
|
european continental ancestry group - statistics & numerical data |
4 |
|
falls |
4 |
|
femur neck - physiology |
4 |
|
forearm - abnormalities |
4 |
|
fracture fixation - methods |
4 |
|
fractures, bone - complications - genetics - physiopathology |
4 |
|
genetic predisposition to disease - genetics |
4 |
|
gestation |
4 |
|
giant cell tumor of bone - complications - diagnosis |
4 |
|
heart failure - etiology |
4 |
|
heritability |
4 |
|
herpesvirus 4, human - isolation & purification |
4 |
|
hip - physiology |
4 |
|
hip fracture |
4 |
|
hip fractures - complications - mortality - surgery |
4 |
|
hkos score |
4 |
|
homeodomain proteins - metabolism |
4 |
|
human genetics |
4 |
|
hyperparathyroidism - complications - diagnosis |
4 |
|
hyperthyroidism - complications - epidemiology - physiopathology |
4 |
|
hypogonadism - diagnosis - ethnology |
4 |
|
hypothyroidism |
4 |
|
hypothyroidism - blood |
4 |
|
implantation rate |
4 |
|
intercellular signaling peptides and proteins - genetics |
4 |
|
internal medicine |
4 |
|
iodide peroxidase - blood - genetics - immunology |
4 |
|
linear models |
4 |
|
litter size |
4 |
|
lumbar vertebrae - physiology |
4 |
|
manufacturers |
4 |
|
mass screening |
4 |
|
medical sciences |
4 |
|
men |
4 |
|
menopause - physiology |
4 |
|
metabolic diseases |
4 |
|
metabolomics |
4 |
|
metabolomics study |
4 |
|
mice, inbred c57bl |
4 |
|
molecular medicine |
4 |
|
mortality |
4 |
|
nasopharyngeal carcinoma |
4 |
|
nasopharyngeal neoplasms - complications - diagnosis |
4 |
|
offspring |
4 |
|
organ size |
4 |
|
osteitis deformans - blood - diagnosis - pathology - therapy |
4 |
|
osteitis deformans - diagnosis |
4 |
|
osteomalacia - etiology |
4 |
|
osteoporotic fractures - complications - mortality - surgery |
4 |
|
osteoporotic fractures - genetics - physiopathology |
4 |
|
osteosclerosis - diagnosis |
4 |
|
outcome |
4 |
|
parathyroid hormone - blood |
4 |
|
parathyroidectomy |
4 |
|
periostin |
4 |
|
polymorphism, genetic |
4 |
|
polymorphism, genetic - genetics |
4 |
|
polymorphism, single nucleotide - genetics |
4 |
|
postmenopause |
4 |
|
practice guidelines |
4 |
|
pregnancy complications - immunology |
4 |
|
preimplantation embryo development |
4 |
|
preoperative care |
4 |
|
pressure ulcer - etiology |
4 |
|
prognosis |
4 |
|
promoter regions, genetic - genetics |
4 |
|
protein binding - genetics |
4 |
|
receptors, calcitriol - genetics |
4 |
|
receptors, calcium-sensing - genetics |
4 |
|
replication |
4 |
|
reproducibility of results |
4 |
|
sequence analysis, dna |
4 |
|
serum calcium |
4 |
|
serum metabolites |
4 |
|
snp |
4 |
|
soft tissue neoplasms - complications - diagnosis |
4 |
|
spinal fractures - genetics - physiopathology |
4 |
|
testosterone |
4 |
|
threshold level |
4 |
|
thyroid |
4 |
|
thyroid peroxidase |
4 |
|
timing of surgery |
4 |
|
transforming growth factor beta - genetics |
4 |
|
triglycerides - blood |
4 |
|
vascular resistance |
4 |
|
ventricular dysfunction, left - epidemiology - etiology - physiopathology - ultrasonography |
4 |
|
vitamin d - therapeutic use |
4 |
|
vitamin d binding protein |
4 |
|
vitamin d insufficiency |
4 |
|
women |
4 |
|
1,25- dihydroxyvitamin d |
3 |
|
acromegaly |
3 |
|
acromegaly - blood - drug therapy |
3 |
|
adenoma - radionuclide imaging - surgery - ultrasonography |
3 |
|
adipose tissue |
3 |
|
administration, inhalation |
3 |
|
adrenal cortex hormones - administration & dosage - adverse effects |
3 |
|
adrenalectomy - adverse effects |
3 |
|
aerosols |
3 |
|
alox15 |
3 |
|
anthropometry |
3 |
|
apolipoprotein a-i - metabolism |
3 |
|
apolipoprotein(a) |
3 |
|
apolipoproteins |
3 |
|
apolipoproteins a - analysis |
3 |
|
arachidonate 15-lipoxygenase - genetics |
3 |
|
asia |
3 |
|
asian |
3 |
|
asian continental ancestry group - genetics - statistics and numerical data |
3 |
|
asthma - drug therapy |
3 |
|
beclomethasone - administration & dosage - adverse effects |
3 |
|
bioimpedance |
3 |
|
bioinformatics |
3 |
|
biopsy, needle |
3 |
|
blindness |
3 |
|
blood glucose - metabolism |
3 |
|
blood pressure - physiology |
3 |
|
body composition |
3 |
|
body fat |
3 |
|
body height |
3 |
|
bone and bones - anatomy & histology |
3 |
|
bone and bones - pathology |
3 |
|
bone density - drug effects - physiology |
3 |
|
bone diseases, metabolic - chemically induced - drug therapy - etiology |
3 |
|
bone loss |
3 |
|
bone marrow transplantation |
3 |
|
bone mass density |
3 |
|
bone size |
3 |
|
brain diseases - complications |
3 |
|
bronchodilator agents - administration & dosage - adverse effects |
3 |
|
budesonide |
3 |
|
calcaneus |
3 |
|
calcaneus - ultrasonography |
3 |
|
calcitriol - blood |
3 |
|
calcitriol - therapeutic use |
3 |
|
calcitropic hormones |
3 |
|
calcium - blood |
3 |
|
calcium - deficiency - metabolism - urine |
3 |
|
calcium absorption |
3 |
|
calcium blood level |
3 |
|
calcium channel agonists - therapeutic use |
3 |
|
calcium radioisotopes - diagnostic use |
3 |
|
candidate gene |
3 |
|
carbimazole - therapeutic use |
3 |
|
carbohydrate metabolism |
3 |
|
cardiac output - physiology |
3 |
|
carrier proteins - blood |
3 |
|
causality |
3 |
|
cell differentiation |
3 |
|
chinese men |
3 |
|
cholesterol |
3 |
|
cholesterol ester transfer proteins |
3 |
|
cholesterol, hdl - blood |
3 |
|
cholesterol, ldl - blood |
3 |
|
choristoma-complications |
3 |
|
chromosome mapping - methods |
3 |
|
chromosomes, human, pair 17 |
3 |
|
chromosomes, human, pair 17 - genetics |
3 |
|
chronic disease |
3 |
|
collagen - urine |
3 |
|
collagen type i |
3 |
|
compound heterozygote |
3 |
|
computational biology - methods |
3 |
|
congenital hypothyroidism |
3 |
|
corticosteroid |
3 |
|
cross-sectional study |
3 |
|
demography |
3 |
|
diabetes insipidus - complications |
3 |
|
diabetes-insipidus-etiology |
3 |
|
different intervention thresholds |
3 |
|
drug tolerance |
3 |
|
echocardiography |
3 |
|
echocardiography, doppler |
3 |
|
electric impedance |
3 |
|
epidermal growth factor - chemistry - metabolism |
3 |
|
esr2 |
3 |
|
estrogens - deficiency |
3 |
|
european continental ancestry group |
3 |
|
european continental ancestry group - genetics |
3 |
|
exons - genetics |
3 |
|
femur - injuries - metabolism |
3 |
|
femur neck - metabolism |
3 |
|
femur neck - physiopathology |
3 |
|
fetal blood - chemistry |
3 |
|
follicle stimulating hormone (fsh) |
3 |
|
fracture incidence |
3 |
|
fracture prevention |
3 |
|
fracture risk |
3 |
|
fractures, bone - epidemiology - etiology - pathology |
3 |
|
fractures, bone - etiology - genetics |
3 |
|
frax |
3 |
|
frax with nhanes t-score |
3 |
|
gender |
3 |
|
gene-environment interaction |
3 |
|
genetic epidemiology |
3 |
|
genetic markers - genetics |
3 |
|
genetic predisposition to disease - ethnology - genetics |
3 |
|
genomics |
3 |
|
gestational diabetes mellitus |
3 |
|
glioma - complications - genetics - metabolism - pathology |
3 |
|
glucose tolerance test |
3 |
|
glycoproteins |
3 |
|
growth hormone |
3 |
|
growth hormone - blood |
3 |
|
handgrip strength |
3 |
|
haplotype |
3 |
|
haplotypes - genetics |
3 |
|
health behavior |
3 |
|
hematopoietic stem cell transplantation |
3 |
|
hemoglobin a, glycosylated - analysis |
3 |
|
heterozygote |
3 |
|
hla |
3 |
|
hla haplotype |
3 |
|
hla-a2 antigen |
3 |
|
hla-b antigens |
3 |
|
hla-dr antigens |
3 |
|
hla-dr serological subtypes |
3 |
|
hormonal replacement therapy |
3 |
|
hyperaldosteronism - diagnosis - surgery |
3 |
|
hyperparathyroidism, primary - etiology |
3 |
|
hyperplasia |
3 |
|
hypertension - epidemiology - etiology |
3 |
|
hypertension, pulmonary - etiology - physiopathology - ultrasonography |
3 |
|
hyperthyroidism - complications - physiopathology - ultrasonography |
3 |
|
hypogonadism - blood - drug therapy |
3 |
|
hypogonadism - complications |
3 |
|
hypothyroidism - etiology |
3 |
|
infant, newborn |
3 |
|
inheritance patterns |
3 |
|
insulin - blood |
3 |
|
insulin-like growth factor i - analysis |
3 |
|
insulinoma - pathology - surgery |
3 |
|
intestinal absorption |
3 |
|
intraoperative period |
3 |
|
introns - genetics |
3 |
|
iodine - administration and dosage - deficiency |
3 |
|
iodine - deficiency - urine |
3 |
|
ldl-receptor related proteins - chemistry - genetics - metabolism |
3 |
|
leukemia, myelogenous, chronic, bcr-abl positive - immunology - therapy |
3 |
|
linkage disequilibrium analysis |
3 |
|
lipase - metabolism |
3 |
|
lipoproteins |
3 |
|
lipoproteins, hdl - metabolism |
3 |
|
liver - enzymology |
3 |
|
logistic discrimination |
3 |
|
lumbar vertebrae - physiopathology |
3 |
|
lupus erythematosus, systemic - complications - drug therapy |
3 |
|
lupus erythematosus, systemic - drug therapy |
3 |
|
luteinizing hormone - blood |
3 |
|
lymphoproliferative disorders - therapy |
3 |
|
matched-pair analysis |
3 |
|
menopausal transition |
3 |
|
menopause |
3 |
|
minimally invasive parathyroidectomy |
3 |
|
models, genetic |
3 |
|
models, molecular |
3 |
|
multimorbidity |
3 |
|
mutation - genetics |
3 |
|
nephritis, interstitial - complications - pathology |
3 |
|
normal |
3 |
|
obesity - diagnosis - ethnology |
3 |
|
octreotide |
3 |
|
octreotide - therapeutic use |
3 |
|
oral glucose tolerance test |
3 |
|
osteocalcin - blood |
3 |
|
osteopenia |
3 |
|
osteoporosis - blood - ethnology - genetics |
3 |
|
osteoporosis - chemically induced |
3 |
|
osteoporosis - chemically induced - drug therapy - physiopathology |
3 |
|
osteoporosis - complications - genetics |
3 |
|
osteoporosis - complications - genetics - metabolism - pathology |
3 |
|
osteoporosis - diagnosis - physiopathology |
3 |
|
osteoporosis - epidemiology - genetics |
3 |
|
osteoporosis - genetics |
3 |
|
osteoporosis pseudoglioma |
3 |
|
osteoporosis, postmenopausal - epidemiology - etiology - pathology |
3 |
|
osteoporosis, postmenopausal - ethnology - metabolism |
3 |
|
osteoporosis, postmenopausal - physiopathology - ultrasonography |
3 |
|
osteoprotegerin |
3 |
|
osteoprotegerin - blood - genetics |
3 |
|
pancreatic neoplasms - pathology - surgery |
3 |
|
paralyses, familial periodic - ethnology - etiology - genetics |
3 |
|
paralyses, familial periodic - etiology |
3 |
|
parathyroid adenoma |
3 |
|
parathyroid neoplasms - radionuclide imaging - surgery - ultrasonography |
3 |
|
peptides - urine |
3 |
|
pituitary-gland |
3 |
|
polymorphism, single nucleotide - physiology |
3 |
|
postmenopause - physiology |
3 |
|
postoperative complications - epidemiology |
3 |
|
postoperative complications - epidemiology - etiology |
3 |
|
postpartum glucose tolerance |
3 |
|
postpartum period |
3 |
|
potassium channels, inwardly rectifying - genetics |
3 |
|
prediction |
3 |
|
pregnancy in diabetics - epidemiology - metabolism |
3 |
|
pregnancy trimester, third |
3 |
|
pregnenediones - administration & dosage - adverse effects |
3 |
|
premenopause - drug effects - metabolism |
3 |
|
premenopause - physiology |
3 |
|
primary hyperparathyroidism |
3 |
|
propylthiouracil - therapeutic use |
3 |
|
protein structure, quaternary |
3 |
|
protein-serine-threonine kinases - genetics |
3 |
|
quality of life |
3 |
|
quantitative trait association |
3 |
|
quantitative trait loci - genetics - physiology |
3 |
|
quantitative ultrasound |
3 |
|
radioactive iodine |
3 |
|
reference values |
3 |
|
regression analysis |
3 |
|
risk assessment - methods |
3 |
|
roc curve |
3 |
|
sample selection |
3 |
|
sella-turcica |
3 |
|
severity of illness index |
3 |
|
skull-neoplasms-complications |
3 |
|
sle |
3 |
|
spinal fractures - physiopathology - ultrasonography |
3 |
|
stem cell transplantation |
3 |
|
steroid |
3 |
|
steroids - adverse effects |
3 |
|
syndrome |
3 |
|
tc99m-sestamibi scintigraphy |
3 |
|
technetium tc 99m sestamibi |
3 |
|
testosterone - blood - therapeutic use |
3 |
|
thyroid function tests |
3 |
|
thyroid gland - metabolism |
3 |
|
thyroiditis, autoimmune - etiology |
3 |
|
thyrotoxicosis |
3 |
|
thyrotoxicosis - complications - ethnology - genetics |
3 |
|
transplantation, autologous |
3 |
|
transplantation, homologous |
3 |
|
triiodothyronine - blood |
3 |
|
ultrasonography |
3 |
|
ultrasound |
3 |
|
variance component |
3 |
|
vascular resistance - physiology |
3 |
|
ventricular function, left - physiology |
3 |
|
vertebral fracture risk |
3 |
|
waist circumference |
3 |
|
young hypogonadal women |
3 |
|
5' flanking region - genetics |
2 |
|
acromegaly - complications - pathology |
2 |
|
acromegaly - etiology |
2 |
|
acute disease |
2 |
|
addison disease - etiology |
2 |
|
adenocarcinoma - complications - secondary |
2 |
|
adenoma - complications - secretion - surgery |
2 |
|
adenoma - diagnosis - secretion |
2 |
|
adenosine triphosphatases - genetics |
2 |
|
administration, cutaneous |
2 |
|
adrenal gland neoplasms - complications |
2 |
|
adrenal gland neoplasms - complications - secondary |
2 |
|
affect - drug effects |
2 |
|
age distribution |
2 |
|
aging - blood - physiology |
2 |
|
aging - metabolism |
2 |
|
alkaloids - pharmacology |
2 |
|
aminoacyltransferases - genetics - metabolism |
2 |
|
androgens - blood - metabolism |
2 |
|
antibodies - immunology |
2 |
|
antibodies, monoclonal |
2 |
|
antigens, cd4 - blood |
2 |
|
antigens, cd8 |
2 |
|
antigens, differentiation, t-lymphocyte - blood |
2 |
|
antineoplastic agents - administration and dosage |
2 |
|
apolipoprotein a-i |
2 |
|
apolipoproteins b - analysis |
2 |
|
asian continental ancestry group - psychology - statistics & numerical data |
2 |
|
asian men |
2 |
|
autoantibodies - analysis |
2 |
|
autoantibodies - biosynthesis |
2 |
|
autoantibodies - immunology |
2 |
|
awareness |
2 |
|
bias correction |
2 |
|
biological availability |
2 |
|
biological markers - analysis |
2 |
|
body water |
2 |
|
body weight - physiology |
2 |
|
bone and bones - embryology - pathology |
2 |
|
bone and bones - metabolism |
2 |
|
bone density conservation agents - pharmacology - therapeutic use |
2 |
|
bone formation |
2 |
|
bone mineral density (bmd) |
2 |
|
bone morphogenetic proteins - genetics |
2 |
|
bone remodeling |
2 |
|
bone turnover |
2 |
|
c-peptide - blood |
2 |
|
calcifediol - blood |
2 |
|
calcium - diagnostic use |
2 |
|
calcium - metabolism |
2 |
|
calcium channels - genetics |
2 |
|
carcinoma, hepatocellular - therapy |
2 |
|
case control study |
2 |
|
cation transport proteins - genetics |
2 |
|
cavernous sinus - pathology |
2 |
|
ccaat-enhancer-binding protein-alpha - metabolism |
2 |
|
cell adhesion molecules, neuronal - genetics |
2 |
|
cell count |
2 |
|
cells, cultured - metabolism |
2 |
|
central obesity |
2 |
|
child, preschool |
2 |
|
chondritis |
2 |
|
chorionic gonadotropin - administration & dosage - pharmacology - therapeutic use |
2 |
|
chromosome mapping |
2 |
|
chromosomes, human, pair 1 - genetics |
2 |
|
computational biology |
2 |
|
construct validation |
2 |
|
cross-over studies |
2 |
|
crtap |
2 |
|
decompression, surgical - methods |
2 |
|
deficiency diseases - diagnosis - epidemiology |
2 |
|
deficiency diseases - epidemiology |
2 |
|
deuterium |
2 |
|
diabetes-insipidus-complications |
2 |
|
diet surveys |
2 |
|
dietary supplements |
2 |
|
dietary survey |
2 |
|
dihydrotestosterone - blood |
2 |
|
discriminative value |
2 |
|
dna primers |
2 |
|
dose-response relationship, radiation |
2 |
|
drug therapy, combination |
2 |
|
education, medical |
2 |
|
embryo, mammalian - metabolism |
2 |
|
endoscopes |
2 |
|
endoscopy - methods |
2 |
|
estrogen receptor (er) |
2 |
|
estrogen receptor alpha |
2 |
|
estrogen receptor beta |
2 |
|
ethnic-specific clinic risk factors |
2 |
|
exophthalmos |
2 |
|
exophthalmos - surgery |
2 |
|
extreme selection |
2 |
|
fertility |
2 |
|
fibroblasts - metabolism |
2 |
|
fibrous dysplasia of bone |
2 |
|
fibrous dysplasia, polyostotic - complications - pathology |
2 |
|
flnb |
2 |
|
follow up |
2 |
|
fracture prediction |
2 |
|
fractures, bone - epidemiology - etiology - genetics |
2 |
|
fractures, bone - epidemiology - physiopathology |
2 |
|
fractures, bone - prevention & control |
2 |
|
gene deletion |
2 |
|
gene-by-environment interactions |
2 |
|
genes - genetics |
2 |
|
genetic linkage - genetics |
2 |
|
genetic markers |
2 |
|
genetic variation |
2 |
|
genetics, population |
2 |
|
genome scan |
2 |
|
genome search |
2 |
|
genome, human |
2 |
|
glucagon - blood |
2 |
|
glucose - pharmacology |
2 |
|
goiter - epidemiology - ultrasonography - urine |
2 |
|
goiter - prevention & control |
2 |
|
gonadotrophins |
2 |
|
graves disease - blood - drug therapy |
2 |
|
graves disease - genetics |
2 |
|
graves disease - metabolism - radiotherapy |
2 |
|
graves disease - radiotherapy |
2 |
|
graves disease - surgery |
2 |
|
graves' disease |
2 |
|
growth hormone - secretion |
2 |
|
health care costs |
2 |
|
health surveys |
2 |
|
health-related quality of life |
2 |
|
hematopoietic stem cell transplantation - adverse effects |
2 |
|
hepatitis b - drug therapy - immunology |
2 |
|
hepatocyte nuclear factor 3-alpha - metabolism |
2 |
|
high-throughput nucleotide sequencing |
2 |
|
hip bmd |
2 |
|
hip fractures - epidemiology - etiology - physiopathology |
2 |
|
hla-dr antigens - blood |
2 |
|
homozygote |
2 |
|
hong kong - ethnology |
2 |
|
hormone replacement therapy |
2 |
|
hormones |
2 |
|
hydrochlorothiazide - therapeutic use |
2 |
|
hypercalciuria |
2 |
|
hyperlipoproteinemia type ii - blood - diet therapy - ethnology |
2 |
|
hypernatremia-complications |
2 |
|
hyperparathyroidism - diagnosis - epidemiology - surgery |
2 |
|
hyperprolactinemia - complications - pathology |
2 |
|
hyperthyroidism - diagnosis - epidemiology |
2 |
|
hypocalcemia |
2 |
|
hypocalcemia - drug therapy - etiology - urine |
2 |
|
hypoglycemia - drug therapy - etiology |
2 |
|
hypogonadism - blood - drug therapy - physiopathology - psychology |
2 |
|
hypogonadism - drug therapy - metabolism |
2 |
|
hypogonadism - drug therapy - pathology |
2 |
|
hypogonadotrophic hypogonadsm |
2 |
|
hypokalemic periodic paralysis - enzymology - genetics |
2 |
|
hyponatremia - etiology |
2 |
|
hypopituitarism - complications - diagnosis - etiology |
2 |
|
hypothyroidism - blood - drug therapy - etiology |
2 |
|
hypothyroidism - diagnosis - epidemiology |
2 |
|
hypothyroidism - immunology |
2 |
|
immunoglobulins, thyroid-stimulating |
2 |
|
infertility |
2 |
|
infertility, male - ethnology - pathology |
2 |
|
inositol - metabolism |
2 |
|
inositol 1,4,5-trisphosphate - metabolism |
2 |
|
inositol phosphates - metabolism |
2 |
|
insulin - secretion |
2 |
|
insulinoma - blood - diagnosis |
2 |
|
interaction |
2 |
|
interferon type ii - pharmacology |
2 |
|
interferon-gamma - adverse effects - therapeutic use |
2 |
|
interleukin-2 - adverse effects - therapeutic use |
2 |
|
intracellular space - metabolism |
2 |
|
iodine |
2 |
|
iodine deficiency |
2 |
|
iodine radioisotopes - adverse effects - therapeutic use |
2 |
|
iodine radioisotopes - metabolism - therapeutic use |
2 |
|
keratitis |
2 |
|
kidney calculi - drug therapy - etiology - urine |
2 |
|
kidney-ultrastructure |
2 |
|
killer cells, lymphokine-activated - transplantation |
2 |
|
knowledge |
2 |
|
language |
2 |
|
laurence-moon-syndrome-pathology |
2 |
|
leucocytospermia |
2 |
|
leukemia, hairy cell - complications - diagnosis - drug therapy |
2 |
|
leukocyte count |
2 |
|
leukocytes - immunology |
2 |
|
life style - ethnology |
2 |
|
linear regression |
2 |
|
lipase - blood |
2 |
|
lipoprotein(a) - blood |
2 |
|
lipoproteins - metabolism |
2 |
|
lipoproteins, hdl - blood |
2 |
|
lipoproteins, ldl - blood |
2 |
|
liver - enzymology - metabolism |
2 |
|
liver neoplasms - therapy |
2 |
|
longitudinal studies |
2 |
|
low-trauma fracture |
2 |
|
lumbar vertebrae - metabolism |
2 |
|
magnetic resonance imaging |
2 |
|
management |
2 |
|
masturbation - epidemiology |
2 |
|
maternal-fetal exchange - immunology |
2 |
|
matn3 |
2 |
|
menotropins - administration & dosage - pharmacology - therapeutic use |
2 |
|
mesenchymal stem cells - cytology - metabolism |
2 |
|
methylenetetrahydrofolate reductase (nadph2) - genetics |
2 |
|
microsatellite |
2 |
|
microsatellite repeats |
2 |
|
microsatellite repeats - genetics |
2 |
|
morphometric fracture |
2 |
|
mri |
2 |
|
muscle proteins - genetics |
2 |
|
muscle strength |
2 |
|
muscle strength - physiology |
2 |
|
mutation |
2 |
|
myasthenia gravis - chemically induced - complications |
2 |
|
myo-inositol |
2 |
|
nandrolone - adverse effects - analogs and derivatives - therapeutic use |
2 |
|
nephrosis,-lipoid-pathology |
2 |
|
nerve compression syndromes - complications |
2 |
|
obesity |
2 |
|
obesity - etiology |
2 |
|
optic nerve - physiopathology |
2 |
|
orbital diseases |
2 |
|
orthopedics and traumatology |
2 |
|
osteoblasts - metabolism - pathology |
2 |
|
osteogenesis |
2 |
|
osteoporosis - complications - physiopathology - psychology |
2 |
|
osteoporosis - diagnosis - drug therapy - psychology |
2 |
|
osteoporosis - epidemiology - genetics - therapy |
2 |
|
osteoporosis - etiology - urine |
2 |
|
osteoporosis - genetics - physiopathology |
2 |
|
osteoporosis - metabolism - pathology |
2 |
|
osteoporosis, postmenopausal - complications - epidemiology - genetics |
2 |
|
osteoporosis, postmenopausal - complications - epidemiology - physiopathology |
2 |
|
osteoporosis, postmenopausal - ethnology - genetics |
2 |
|
osteoporotic fracture |
2 |
|
osteoporotic fractures - epidemiology - etiology - physiopathology |
2 |
|
osteosclerosis - blood - etiology - radiography - radionuclide imaging |
2 |
|
pancreatectomy |
2 |
|
pancreatic neoplasms - blood - diagnosis |
2 |
|
pancreatic neoplasms - complications - secretion - surgery |
2 |
|
paralyses, familial periodic - genetics |
2 |
|
parathyroidectomy - methods - statistics & numerical data |
2 |
|
parity |
2 |
|
phenotype |
2 |
|
pheochromocytoma - complications |
2 |
|
physicians - psychology |
2 |
|
phytosterols - blood |
2 |
|
pilot projects |
2 |
|
pituitary gland - enzymology |
2 |
|
pituitary gland - pathology |
2 |
|
pituitary neoplasms - diagnosis - secretion |
2 |
|
pituitary tumour |
2 |
|
polymerase chain reaction |
2 |
|
polymorphism |
2 |
|
polymorphism, restriction fragment length |
2 |
|
postmenopause - genetics |
2 |
|
postoperative complications |
2 |
|
potassium channels - genetics |
2 |
|
potassium channels, voltage-gated |
2 |
|
practice guidelines as topic |
2 |
|
pregnancy - physiology |
2 |
|
pregnancy complications - epidemiology - ultrasonography |
2 |
|
pregnancy complications - epidemiology - ultrasonography - urine |
2 |
|
pregnancy trimester, first |
2 |
|
pregnancy trimester, second |
2 |
|
pregnancy trimesters |
2 |
|
premenopause - genetics |
2 |
|
probability |
2 |
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase - genetics |
2 |
|
propranolol - adverse effects |
2 |
|
protein binding |
2 |
|
protein subunits - genetics |
2 |
|
qtl association |
2 |
|
qualeffo-31 |
2 |
|
quality of life - psychology |
2 |
|
quantitative trait loci - genetics |
2 |
|
radiotherapy - adverse effects |
2 |
|
raloxifene - therapeutic use |
2 |
|
receptors, cannabinoid - genetics |
2 |
|
receptors, estrogen - genetics |
2 |
|
receptors, tumor necrosis factor, type ii - genetics |
2 |
|
recombinant proteins - adverse effects |
2 |
|
regulatory sequences, nucleic acid - genetics |
2 |
|
rhabdomyolysis-etiology |
2 |
|
sclerostin |
2 |
|
selective estrogen receptor modulators - therapeutic use |
2 |
|
selective genotyping |
2 |
|
semen - cytology |
2 |
|
seminal leucocytes |
2 |
|
sensitivity and specificity |
2 |
|
sex characteristics |
2 |
|
sex distribution |
2 |
|
sexual behavior - drug effects |
2 |
|
shaw potassium channels |
2 |
|
skin - metabolism - pathology |
2 |
|
smit1 |
2 |
|
sodium channels - genetics |
2 |
|
sodium chloride - chemistry |
2 |
|
sodium-potassium-exchanging atpase - genetics |
2 |
|
somatostatin |
2 |
|
somatostatin - analogs & derivatives - therapeutic use |
2 |
|
somatostatin - blood |
2 |
|
sperm function |
2 |
|
spermatogenesis |
2 |
|
spermatogenesis - drug effects |
2 |
|
spermatozoa |
2 |
|
stimulation, chemical |
2 |
|
subtotal thyroidectomy |
2 |
|
survey |
2 |
|
symporters - deficiency - metabolism |
2 |
|
t-lymphocyte subsets - drug effects |
2 |
|
tag snps |
2 |
|
terminal repeat sequences - genetics |
2 |
|
testicular volume |
2 |
|
testosterone - administration & dosage - metabolism |
2 |
|
testosterone - blood - metabolism |
2 |
|
tgf-β1 |
2 |
|
thyroglobulin - blood |
2 |
|
thyroid diseases - blood |
2 |
|
thyroid diseases - etiology - physiopathology |
2 |
|
thyroid gland - drug effects - physiology |
2 |
|
thyroid gland - immunology - physiopathology |
2 |
|
thyroid gland - radiation effects |
2 |
|
thyroid gland - ultrasonography |
2 |
|
thyroid nodule - epidemiology - etiology - ultrasonography |
2 |
|
thyroidectomy - methods |
2 |
|
thyroiditis, autoimmune - chemically induced |
2 |
|
thyrotoxic periodic paralysis |
2 |
|
thyrotoxicosis - etiology |
2 |
|
thyrotoxicosis - genetics |
2 |
|
thyroxine - analysis |
2 |
|
thyroxine - blood - deficiency |
2 |
|
tomography, x-ray computed |
2 |
|
total thyroidectomy |
2 |
|
transcription, genetic |
2 |
|
transforming growth factor beta - blood - genetics |
2 |
|
transforming growth factor beta1 |
2 |
|
transient neonatal hypothyroidism |
2 |
|
transplantation |
2 |
|
tsh-blocking antibodies |
2 |
|
water - chemistry |
2 |
|
xanthogranuloma, juvenile - blood - diet therapy - ethnology |
2 |
|
多態性單核苷酸(polymorphism, single nucleotide) |
2 |
|
連鎖圖(mapping, linkage) |
2 |
|
遺傳標記(genetic markers) |
2 |
|
骨質疏松(osteoporosis) |
2 |
|
骨質疏松性骨折(osteoporotic fractures) |
2 |
|
absolute risk |
1 |
|
absorptiometry, photon - standards |
1 |
|
accidental falls - prevention & control |
1 |
|
acidosis, renal tubular - complications - etiology |
1 |
|
actaea racemosa |
1 |
|
adaptation, psychological |
1 |
|
adenocarcinoma - complications - pathology |
1 |
|
adherence |
1 |
|
adrenal gland |
1 |
|
adrenalectomy - methods |
1 |
|
adrenergic beta-antagonists - therapeutic use |
1 |
|
adrenocortical hyperfunction - diagnosis - surgery |
1 |
|
adrenocorticotropic hormone - secretion |
1 |
|
african continental ancestry group |
1 |
|
age |
1 |
|
aging - physiology |
1 |
|
aimah |
1 |
|
alendronate |
1 |
|
alendronate - administration & dosage |
1 |
|
alendronate - administration & dosage - adverse effects - therapeutic use |
1 |
|
alendronate - pharmacology - therapeutic use |
1 |
|
alendronate - therapeutic use |
1 |
|
alkaline phosphatase |
1 |
|
alkaline phosphatase - antagonists & inhibitors - blood |
1 |
|
amino acid sequence |
1 |
|
androgens - metabolism - physiology - therapeutic use |
1 |
|
antibodies, antineutrophil cytoplasmic |
1 |
|
antibodies, blocking - blood |
1 |
|
antibodies, blocking - immunology - metabolism |
1 |
|
antibody formation |
1 |
|
antigens, cd - biosynthesis |
1 |
|
antigens, cd5 |
1 |
|
antineoplastic agents - therapeutic use |
1 |
|
antithyroid agents |
1 |
|
arthritis, rheumatoid - immunology |
1 |
|
artifacts |
1 |
|
asia - epidemiology |
1 |
|
asia - ethnology |
1 |
|
asia, southeastern |
1 |
|
asia-pacific standards |
1 |
|
asian continental ancestry group - ethnology |
1 |
|
asian women |
1 |
|
autoantibodies - immunology - metabolism |
1 |
|
autoimmune, disease |
1 |
|
b-lymphocyte subsets - immunology |
1 |
|
b-lymphocytes - immunology |
1 |
|
bazedoxifene |
1 |
|
binding sites |
1 |
|
biological markers - blood |
1 |
|
biological markers - blood - urine |
1 |
|
bisphosphonate |
1 |
|
black cohosh |
1 |
|
blood flow velocity - drug effects |
1 |
|
blotting, northern |
1 |
|
body temperature |
1 |
|
bone and bones - drug effects |
1 |
|
bone and bones - enzymology |
1 |
|
bone and bones - pathology - physiology |
1 |
|
bone and bones - ultrasonography |
1 |
|
bone and bones/drug effects/metabolism |
1 |
|
bone densitometry |
1 |
|
bone density conservation agents - administration & dosage - adverse effects - therapeutic use |
1 |
|
bone density conservation agents - administration and dosage - adverse effects |
1 |
|
bone density conservation agents - adverse effects - therapeutic use |
1 |
|
bone density conservation agents - therapeutic use |
1 |
|
bone marker |
1 |
|
bone markers |
1 |
|
bone remodeling - drug effects |
1 |
|
bone remodeling - drug effects - physiology |
1 |
|
bone resorption - chemically induced - genetics - prevention & control |
1 |
|
bone resorption - etiology - prevention & control |
1 |
|
bone ultrasound |
1 |
|
boundary matching |
1 |
|
bucladesine - pharmacology |
1 |
|
calcitonin |
1 |
|
calcitonin - pharmacology |
1 |
|
calcitonin - pharmacology - therapeutic use |
1 |
|
calcium - administration & dosage |
1 |
|
calcium, dietary |
1 |
|
cell differentiation - drug effects |
1 |
|
cell division |
1 |
|
cell proliferation |
1 |
|
cells, cultured |
1 |
|
cho cells |
1 |
|
cimicifuga - metabolism |
1 |
|
cimicifuga racemosa |
1 |
|
clinical assessment tool |
1 |
|
clinical risk index |
1 |
|
clinical trials as topic |
1 |
|
cognition disorders - drug therapy - etiology |
1 |
|
colia1 gene polymorphisms |
1 |
|
collagen - antagonists & inhibitors - urine |
1 |
|
collagen - genetics |
1 |
|
compliance |
1 |
|
contraceptives, oral, hormonal - pharmacology |
1 |
|
core binding factor alpha 1 subunit - biosynthesis |
1 |
|
core binding factor alpha 1 subunit - metabolism |
1 |
|
cost-benefit analysis |
1 |
|
cricetinae |
1 |
|
cushing syndrome - diagnosis - surgery |
1 |
|
cushing's syndrome |
1 |
|
cyclic amp - biosynthesis |
1 |
|
cytokines - biosynthesis |
1 |
|
data display |
1 |
|
deficiency |
1 |
|
deficiency diseases |
1 |
|
deficiency diseases - epidemiology - prevention and control |
1 |
|
diabetes mellitus, type 2 - drug therapy - physiopathology |
1 |
|
diagnosis |
1 |
|
diagnosis, computer-assisted |
1 |
|
diet |
1 |
|
dimethyl sulfoxide - pharmacology |
1 |
|
diphosphonates - administration and dosage - adverse effects |
1 |
|
dmso |
1 |
|
dna, complementary - genetics |
1 |
|
dose-response relationship, drug |
1 |
|
double-blind method |
1 |
|
drug administration schedule |
1 |
|
drug information sheet |
1 |
|
educational measurement |
1 |
|
electromyography |
1 |
|
endocrinology |
1 |
|
endocrinology - methods |
1 |
|
enzyme activation - drug effects |
1 |
|
enzyme-linked immunosorbent assay |
1 |
|
epidermal growth factor - analysis - blood |
1 |
|
epidermal growth factor - pharmacology |
1 |
|
epitopes - analysis |
1 |
|
epitopes - immunology |
1 |
|
epitopes, t-lymphocyte |
1 |
|
erk |
1 |
|
estradiol - analogs & derivatives - pharmacology |
1 |
|
estrogen |
1 |
|
estrogen antagonists - administration & dosage - adverse effects |
1 |
|
estrogen antagonists - pharmacology |
1 |
|
estrogen receptor |
1 |
|
estrogens - physiology |
1 |
|
estrogens, non-steroidal - pharmacology |
1 |
|
ethanol - pharmacology |
1 |
|
ethanol - toxicity |
1 |
|
ethinyl estradiol - administration & dosage - pharmacology |
1 |
|
ethnicity |
1 |
|
etidronic acid - adverse effects - analogs & derivatives - pharmacology - therapeutic use |
1 |
|
etidronic acid - analogs & derivatives - therapeutic use |
1 |
|
etidronic acid - pharmacology |
1 |
|
exercise |
1 |
|
eye diseases - etiology - immunology - prevention & control |
1 |
|
far east - epidemiology |
1 |
|
fatal outcome |
1 |
|
feedback |
1 |
|
femur |
1 |
|
femur neck - pathology - radiography |
1 |
|
femur neck - radiography |
1 |
|
forskolin - pharmacology |
1 |
|
fracture risk prediction tool |
1 |
|
fractures |
1 |
|
fractures, bone - etiology - physiopathology |
1 |
|
fractures, bone - etiology - prevention & control |
1 |
|
fractures, bone - physiopathology - radiography |
1 |
|
gastric acid - secretion |
1 |
|
gastric mucosa - blood supply - drug effects |
1 |
|
gene expression - drug effects |
1 |
|
gene expression regulation |
1 |
|
gene expression regulation - drug effects |
1 |
|
geographic variability |
1 |
|
glomerulonephritis, iga - immunology |
1 |
|
glucocorticoids - therapeutic use |
1 |
|
glycosaminoglycans - urine |
1 |
|
goiter - epidemiology - prevention and control |
1 |
|
goiter, nodular - diagnosis |
1 |
|
graves disease - blood - drug therapy - immunology |
1 |
|
graves disease - blood - immunology |
1 |
|
graves disease - complications - diagnosis - therapy |
1 |
|
graves disease - complications - radiotherapy |
1 |
|
graves disease - diagnosis |
1 |
|
graves disease - drug therapy - physiopathology - urine |
1 |
|
graves disease - etiology - psychology |
1 |
|
graves disease - immunology |
1 |
|
graves disease - metabolism |
1 |
|
graves-disease-complications |
1 |
|
health education |
1 |
|
health-knowledge,-attitudes,-practice |
1 |
|
health-surveys |
1 |
|
hemorrhage |
1 |
|
hip - radiography |
1 |
|
hip fractures - diagnosis - ethnology |
1 |
|
hip fractures - ethnology - physiopathology |
1 |
|
hip fractures - prevention & control - rehabilitation |
1 |
|
hip joint - metabolism |
1 |
|
hispanic americans |
1 |
|
hormones - therapeutic use |
1 |
|
human thyrocytcs |
1 |
|
humdisease |
1 |
|
hyperparathyroidism - drug therapy - metabolism |
1 |
|
hyperparathyroidism, primary - drug therapy |
1 |
|
hyperparathyroidism, secondary |
1 |
|
hyperthyroidism - blood |
1 |
|
hyperthyroidism - complications - drug therapy - psychology |
1 |
|
hyperthyroidism-etiology |
1 |
|
hypoglycemia |
1 |
|
hypoglycemic agents - therapeutic use |
1 |
|
hypogonadism - pathology |
1 |
|
hypokalemia - complications - drug therapy |
1 |
|
hypokalemia - etiology |
1 |
|
hypokalemic periodic paralysis |
1 |
|
hypokalemic periodic paralysis - genetics - metabolism |
1 |
|
hypothyroidism - epidemiology - etiology |
1 |
|
hypothyroidism - epidemiology - prevention and control |
1 |
|
ibandronate |
1 |
|
ici 182 780 |
1 |
|
image enhancement - instrumentation |
1 |
|
image processing, computer-assisted - instrumentation |
1 |
|
image sequence compression |
1 |
|
immunization |
1 |
|
immunoblotting |
1 |
|
immunodominant epitopes |
1 |
|
immunoglobulin g |
1 |
|
immunoglobulin g - blood |
1 |
|
immunoglobulin g - immunology |
1 |
|
immunoglobulin g - physiology |
1 |
|
immunoglobulins, thyroid-stimulating - blood |
1 |
|
immunoglobulins, thyroid-stimulating - blood - immunology |
1 |
|
immunoglobulins, thyroid-stimulating - immunology - metabolism |
1 |
|
indoles - administration & dosage - adverse effects - therapeutic use |
1 |
|
indoles - therapeutic use |
1 |
|
insulin |
1 |
|
interferon-gamma - biosynthesis |
1 |
|
interferon-gamma - pharmacology |
1 |
|
interferon-gamma - physiology |
1 |
|
interferon‐gamma |
1 |
|
interleukin-1 - pharmacology |
1 |
|
interleukin-10 - biosynthesis |
1 |
|
interleukin-12 - biosynthesis |
1 |
|
interleukin-4 - biosynthesis |
1 |
|
interleukin-6 - biosynthesis |
1 |
|
international variability |
1 |
|
iodide peroxidase - genetics |
1 |
|
iodide peroxidase - immunology |
1 |
|
iodide peroxidase - metabolism |
1 |
|
iodine - administration & dosage - deficiency - metabolism |
1 |
|
iodine - administration & dosage - urine |
1 |
|
iodine radioisotopes - adverse effects - pharmacokinetics - therapeutic use |
1 |
|
iodine radioisotopes - therapeutic use |
1 |
|
isoflavones - administration & dosage - pharmacology |
1 |
|
kidney calculi - therapy |
1 |
|
lactation |
1 |
|
lactation - metabolism - physiology |
1 |
|
laparoscopic |
1 |
|
levonorgestrel |
1 |
|
life change events |
1 |
|
lipids - blood |
1 |
|
lumbar vertebrae |
1 |
|
lumbar vertebrae - anatomy & histology |
1 |
|
lumbosacral region |
1 |
|
lung neoplasms - complications - pathology |
1 |
|
lymphocyte activation |
1 |
|
lymphocytic thyroiditis |
1 |
|
magnetic resonance imaging - methods |
1 |
|
malaysia - epidemiology |
1 |
|
maternal nutritional physiological phenomena - physiology |
1 |
|
mc3t3-e1 |
1 |
|
medical diagnosis |
1 |
|
medline |
1 |
|
methimazole |
1 |
|
methimazole - therapeutic use |
1 |
|
mice, inbred cba |
1 |
|
microscopy, electron |
1 |
|
microvilli - ultrastructure |
1 |
|
molecular sequence data |
1 |
|
mrna |
1 |
|
multivariate analysis |
1 |
|
muscle, skeletal - physiopathology |
1 |
|
muscular diseases - diagnosis - etiology - therapy |
1 |
|
musculoskeletal diseases - epidemiology - etiology |
1 |
|
myelolipomatous |
1 |
|
neoplasms, glandular and epithelial - epidemiology - pathology - therapy |
1 |
|
neuromuscular diseases - drug therapy - etiology - psychology |
1 |
|
norgestrel - administration & dosage - pharmacology |
1 |
|
nucleic acid hybridization |
1 |
|
nutritional requirements |
1 |
|
nutritional status |
1 |
|
oligonucleotide probes |
1 |
|
once-weekly regimen |
1 |
|
organometallic compounds - adverse effects - therapeutic use |
1 |
|
osta |
1 |
|
osteoblast |
1 |
|
osteoblasts |
1 |
|
osteoblasts - cytology - metabolism |
1 |
|
osteoblasts - enzymology |
1 |
|
osteocalcin - biosynthesis |
1 |
|
osteocalcin - genetics |
1 |
|
osteogenesis - drug effects |
1 |
|
osteoporosis - chemically induced - prevention & control |
1 |
|
osteoporosis - complications - physiopathology |
1 |
|
osteoporosis - drug therapy |
1 |
|
osteoporosis - economics - epidemiology - etiology - prevention & control |
1 |
|
osteoporosis - ethnology - prevention & control |
1 |
|
osteoporosis - physiopathology - radiography |
1 |
|
osteoporosis, postmenopausal - complications - drug therapy |
1 |
|
osteoporosis, postmenopausal - complications - ethnology - ultrasonography |
1 |
|
osteoporosis, postmenopausal - diagnosis - ethnology |
1 |
|
osteoporosis, postmenopausal - drug therapy |
1 |
|
osteoporosis, postmenopausal - drug therapy - ethnology - metabolism |
1 |
|
osteoporosis, postmenopausal - drug therapy - ethnology - physiopathology |
1 |
|
osteoporosis, postmenopausal - drug therapy - physiopathology |
1 |
|
osteoporosis, postmenopausal - drug therapy - psychology |
1 |
|
osteoporosis, postmenopausal - epidemiology - etiology |
1 |
|
osteoporosis, postmenopausal - metabolism - prevention and control |
1 |
|
osteoporosis, postmenopausal - prevention & control |
1 |
|
osteoporosis-prevention-and-control |
1 |
|
osteoporotic fractures |
1 |
|
osteoporotic fractures - diagnosis - ethnology |
1 |
|
osteoporotic fractures - ethnology - physiopathology |
1 |
|
osteoporotic fractures - etiology - prevention & control |
1 |
|
osteoporotic fractures - prevention & control - rehabilitation |
1 |
|
ovarian-neoplasms-complications |
1 |
|
pacific islands |
1 |
|
paralysis - diagnosis - etiology - therapy |
1 |
|
patient compliance |
1 |
|
patient education |
1 |
|
patient education as topic |
1 |
|
patient satisfaction |
1 |
|
peak bone mass |
1 |
|
pelvic bones |
1 |
|
peptide fragments - immunology |
1 |
|
peptides - antagonists & inhibitors - urine |
1 |
|
periodicity |
1 |
|
phytoestrogens |
1 |
|
pkd |
1 |
|
placebos |
1 |
|
plant extracts - pharmacology |
1 |
|
plant preparations |
1 |
|
platelet count |
1 |
|
postmenopausal |
1 |
|
postmenopausal women |
1 |
|
postmenopause - blood |
1 |
|
postoperative period |
1 |
|
postpartum period - blood - immunology |
1 |
|
potassium - metabolism |
1 |
|
potassium channels, inwardly rectifying - chemistry - genetics - metabolism |
1 |
|
potassium chloride - administration & dosage |
1 |
|
precipitin tests |
1 |
|
prednisone - therapeutic use |
1 |
|
preference |
1 |
|
pregnancy complications |
1 |
|
pregnancy complications - blood - immunology |
1 |
|
pregnancy in diabetics |
1 |
|
pregnancy-complications |
1 |
|
pregnancy-complications,-neoplastic |
1 |
|
prevalence |
1 |
|
prevalence, hong kong |
1 |
|
primary prevention |
1 |
|
proliferation |
1 |
|
protein kinase c |
1 |
|
protein kinase c - metabolism |
1 |
|
proteins |
1 |
|
puberty - physiology |
1 |
|
race/ethnicity |
1 |
|
radioimmunoassay |
1 |
|
radius - metabolism |
1 |
|
raloxifene |
1 |
|
raloxifene - administration & dosage - adverse effects |
1 |
|
rats |
1 |
|
rats, sprague-dawley |
1 |
|
receptors, androgen - metabolism |
1 |
|
receptors, thyrotropin - analysis |
1 |
|
receptors, thyrotropin - blood |
1 |
|
receptors, thyrotropin - genetics - immunology - metabolism |
1 |
|
receptors, thyrotropin - immunology |
1 |
|
recombinant proteins - immunology |
1 |
|
recombinant proteins - pharmacology |
1 |
|
regional blood flow - drug effects |
1 |
|
rheumatoid factor - biosynthesis |
1 |
|
ribs - radiography |
1 |
|
risedronate |
1 |
|
rna, messenger - biosynthesis |
1 |
|
rna, messenger - biosynthesis - genetics |
1 |
|
rna, messenger - genetics |
1 |
|
rna, messenger - genetics - metabolism |
1 |
|
safety |
1 |
|
selective estrogen receptor modulator |
1 |
|
selective estrogen receptor modulators - administration & dosage - adverse effects - therapeutic use |
1 |
|
serms |
1 |
|
signal transduction - drug effects |
1 |
|
signaling |
1 |
|
size |
1 |
|
sjogren's syndrome - complications |
1 |
|
societies, medical |
1 |
|
sodium-potassium-exchanging atpase - metabolism |
1 |
|
solvents - pharmacology |
1 |
|
southern chinese |
1 |
|
southern chinese population |
1 |
|
soybeans |
1 |
|
spinal fractures - diagnosis - epidemiology - radiography |
1 |
|
spinal fractures - epidemiology |
1 |
|
spinal fractures - etiology - prevention & control |
1 |
|
spine - metabolism |
1 |
|
spine - radiography |
1 |
|
steroid therapy |
1 |
|
sterols - blood |
1 |
|
stress, psychological - complications |
1 |
|
strontium ranelate |
1 |
|
submandibular gland - surgery |
1 |
|
sulfonylurea |
1 |
|
sunlight- |
1 |
|
t-lymphocytes - pathology |
1 |
|
t-lymphocytes, regulatory - immunology |
1 |
|
teriparatide |
1 |
|
teriparatide - pharmacology - therapeutic use |
1 |
|
testosterone - physiology |
1 |
|
tetradecanoylphorbol acetate - pharmacology |
1 |
|
thailand - epidemiology |
1 |
|
thermography |
1 |
|
thermography - instrumentation |
1 |
|
thiophenes - adverse effects - therapeutic use |
1 |
|
thiouracil |
1 |
|
thoracic vertebrae - injuries - radiography |
1 |
|
thymic hyperplasia |
1 |
|
thymus hyperplasia - complications - radiography |
1 |
|
thyroglobulin |
1 |
|
thyroglobulin - analysis |
1 |
|
thyroglobulin - biosynthesis |
1 |
|
thyroglobulin - genetics |
1 |
|
thyroglobulin - genetics - secretion |
1 |
|
thyroid autoimmunity |
1 |
|
thyroid conditioning monitoring |
1 |
|
thyroid diseases - diagnosis - physiopathology |
1 |
|
thyroid diseases - epidemiology |
1 |
|
thyroid gland |
1 |
|
thyroid gland - anatomy & histology |
1 |
|
thyroid gland - cytology - enzymology |
1 |
|
thyroid gland - immunology |
1 |
|
thyroid gland - pathology |
1 |
|
thyroid gland - secretion |
1 |
|
thyroid gland - ultrastructure |
1 |
|
thyroid hormone |
1 |
|
thyroid hormones - physiology |
1 |
|
thyroid neoplasms - blood - surgery |
1 |
|
thyroid neoplasms - diagnosis - pathology - secondary |
1 |
|
thyroid neoplasms - epidemiology - pathology - therapy |
1 |
|
thyroidectomy |
1 |
|
thyroiditis |
1 |
|
thyroiditis - diagnosis - etiology - pathology |
1 |
|
thyroiditis - pathology - physiopathology |
1 |
|
thyroiditis, autoimmune - blood - immunology - pathology |
1 |
|
thyroiditis, autoimmune - drug therapy - physiopathology |
1 |
|
thyrotoxicosis - complications - diagnosis - therapy |
1 |
|
thyrotoxicosis - complications - drug therapy - psychology |
1 |
|
thyrotoxicosis - complications - radiography |
1 |
|
thyrotoxicosis - diagnosis |
1 |
|
thyrotoxicosis - immunology - radiotherapy |
1 |
|
thyrotropin - blood - immunology |
1 |
|
thyrotropin - pharmacology |
1 |
|
thyrotropin - physiology |
1 |
|
thyroxine - adverse effects - blood - therapeutic use |
1 |
|
thyroxine - blood - pharmacology |
1 |
|
thyroxine - therapeutic use |
1 |
|
transcription, genetic - drug effects |
1 |
|
transcriptional activation |
1 |
|
transfection |
1 |
|
treatment |
1 |
|
tumor necrosis factor-alpha - biosynthesis |
1 |
|
ultrastructural changes |
1 |
|
urinary iodine |
1 |
|
videotape recording |
1 |
|
vitamin d - administration & dosage |
1 |
|
vitamin d deficiency - blood - epidemiology |
1 |
|
vitamin d deficiency - complications - epidemiology |
1 |
|
vitamin d receptor |
1 |
|
vitamin-d-deficiency-prevention-and-control |
1 |
|
weekly |
1 |
|
young women |
1 |
